Comment on: Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. [N Engl J Med. 2019] Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. [N Engl J Med. 2019] Direct Oral Anticoagulants for Thromboprophylaxis in Ambulatory Patients with Cancer. [N Engl J Med. 2019]
Preventing Venous Thromboembolism in Patients with Cancer
D'Ambrosio, Lorenzo;Aglietta, Massimo;
2019-01-01
Abstract
Comment on: Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. [N Engl J Med. 2019] Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. [N Engl J Med. 2019] Direct Oral Anticoagulants for Thromboprophylaxis in Ambulatory Patients with Cancer. [N Engl J Med. 2019]
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
nejmc1904003.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
64.14 kB
Formato
Adobe PDF
|
64.14 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
